Innovation and productivity in health systems

Download
Download

The latest PharmaFutures dialogue extends the analysis of its most recent report, opening up the conversation to include payers, regulators and other societal and government experts as well as assessing new trends in reimbursement, innovation and productivity.

Run over two years, PharmaFutures 5 analyses key trends that are reshaping the reimbursement landscape for medicines around the world. With greater use of data, more patient involvement and a focus on improving patient outcomes with limited resources, payers are redefining the value that medicines bring to health systems. PharmaFutures 5 argues for a new approach to drug research, licensing and pricing that would introduce more flexibility into the system. This will require unprecedented levels of collaboration among key stakeholders, including pharma, regulators, payers and patients.

The conclusions from the PharmaFutures dialogue can be found in the new report: “Pathways to Value: Pharma in a Changing World” published in June 2013. Specific regional analysis can be found in the three regional reports below.

Download PharmaFutures 5

Download

Download PharmaFutures from Emerging Markets

Download

Download PharmaFutures Report Pharmas New Productivity Challenge Cost and Choice in the US Market

Download